Form D · Biotechnology
HydRx Farms Ltd.
Whitby, A6 · CIK 0001732456
Offering snapshot reported Mar 2, 2018 · SEC filing
- Reported sold
- $1.88M Offering amount: $1.88M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 15, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 2, 2018 | Initial | $1,884,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $207K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-306821
Estimated USD offering amount is based on CAD$1.25/USD$1.00 exchange rate.
Based on CAD/USD exchange rate. Includes estimated value of options issued as part of sales commissions.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| GMP Securities L.P. | 40620 |
Source: Form D, filed Mar 2, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ravpreet Grover | Executive, Promoter |
| Har Grover | Director, Executive, Promoter |
| Philip Hemans | Executive, Promoter |
| Thomas Jefferd | Executive |
| Ovidiu Purdel | Executive |
| Derek Riley | Director |
| Domenic Serafino | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
209 Dundas Street East
Whitby, A6, L1N 5R7
Whitby, A6, L1N 5R7